Browsing by Subject "HAART"
Now showing items 1-20 of 30
-
Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods a prospective cohort study
(Adis, 2012-10)Background: The effectiveness of traditional adherence measurements used in adolescent populations isdifficult to assess. Antiretroviral (ARV) adherence research among adolescents living with HIV in resourceconstrained ... -
Antiretroviral therapy improves cognitive impairment in HIV individuals in Sub-Saharan Africa
(American Academy of Neurology (AAN), 2006)Abstract—Background: Highly active antiretroviral therapy (HAART) can improve cognitive performance in some patients with HIV-associated cognitive impairment in the United States. The effect of HAART on HIV dementia ... -
Biomarkers of HIV immune reconstitution inflammatory syndrome
(Future Medicine, 2008)Dysregulation of the immune system drives HIV pathogenesis. As we develop new ways to treat HIV and AIDS, we encounter new clinical ramifications of our treatment on regulatory components of the Immune system. HIV-associated ... -
CDd4 t- cell immune responses in haart-treated hiv-infected adults who attain normal CD4 counts in a Ugandan cohort
(Makerere University, 2014-05)Background: Majority of HIV-infected individuals who start HAART at CD4 counts <200 cells/µl show a marked CD4+T-cell increase to absolute CD4 counts above 500 cells/µl. The CD4+ T-cell count is the main measure for immune ... -
Coping with TB immune reconstitution inflammatory syndrome
(Expert Reviews, 2009)The TB immune reconstitution inflammatory syndrome (IRIS) is a relatively frequent complication in HIV–TB-coinfected patients after they start highly active antiretroviral therapy (HAART). There are two forms of TB IRIS: ... -
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
(BMC Psychiatry, 2010)Background: Among patients with HIV infection, depression is the most frequently observed psychiatric disorder. The presence of depressive symptoms and cognitive dysfunction among HIV patients has not been well studied in ... -
Documentation and propagation of medicinal plants used for HIV/AIDS management in Mpigi District, Uganda
(Makerere University, 2013-03)HIV/AIDS continues to exact a large toll on humans everywhere in the world. Currently western medicine remains the treatment of choice. However, it does not provide a complete cure. Treatment outcome from HAART is further ... -
Evaluation of patients' response to treatment with highly active antiretroviral therapy at the Infectious Diseases Institute, Kampala.
(2009-10)BACKGROUND: In Africa, a consideration number of clients get diagnosed with HIV for the first time after a WHO stage 4 illness. Evidence in the developed world shows that individuals who initiate ART with advanced HIV/AIDS ... -
Factors affecting adherence to cotrimoxazole prophylaxis among HIV/AIDS patients in Rukungiri District, Uganda.
(2009)INTRODUCTION: Globally, 33 million people are estimated to be living with HIV of which 22 million are in sub Saharan Africa. In Rukungiri district, 20115 people were estimated to be living with HIV/AIDS. With adherence ... -
Factors influencing the acceptance of directly observed therapy in the delivery of anti-retroviral drugs for treatment of Human Immunodeficiency Virus in Urban Uganda
(2008-05)Background: Directly observed therapy for highly active antiretroviral therapy (DOT-HAART) has the potential to improve adherence and social support in HIV+ patients. Aims were to determine; the level of DOT-HAART acceptance, ... -
Hearing loss associated with Kanamycin in patients treated for multi-drug-resistant Tuberculosis at Mulago Hospital
(Makerere University, 2016)Introduction Aminoglycosides form part of the second-line drugs used in treatment of Multi-drug resistant tuberculosis. Cochleotoxicity is one of the side effects of aminoglycosides. It usually presents as permanent, ... -
High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort
(BMC Immunology, 2014)Background: Up to 40% of HIV-infected individuals receiving Highly Active Antiretroviral Therapy (HAART) have poor CD4+ T-cell recovery. The role of natural killer (NK) cells in immune recovery during HAART is not well ... -
HIV Eosinophilic Folliculitis in Uganda
(American Medical Association (AMA), 2006) -
HIV immune reconstitution syndrome in sub-Saharan Africa
(Lippincott Williams & Wilkins, 2008)Over the last 5 years, there has been remarkable progress in providing HAART to patients in developing countries. In sub-Saharan Africa alone, the number receiving antiretroviral therapy (ART) has more than doubled in ... -
Implementing the right to health of women on antiretroviral therapy: a case of reach out Mbuya HIV/AIDS initiative in Uganda.
(Makerere University, 2009-10)The study set out to assess how Reach Out Mbuya HIV/AIDS Initiative implements the right to health for women on ART, in light of national and international guidelines. Particularly the study focused on international and ... -
In vivo PPD reactivity and associated factors among HIV positive patients on HAART at the Makerere University Infectious Diseases Clinic.
(2009-08)BACKGROUND: It is estimated that a third of the world’s population is infected with tuberculosis (TB). This epidemic is fueled by HIV, with reactivation rates of 8-10% / year and overall lifetime risk of 30% in HIV ... -
Lack of association between fluconazole susceptibility and ERG11 nucleotide polymorphisms in cryptococcus neoformans clinical isolates from Uganda
(Makerere University, 2022-08)Over 50% of Ugandan HIV-infected patients die due to cryptococcal meningitis [CM]-related complications. Fluconazole is the drug of choice for CM monoprophylaxis in resource-limited settings such as Uganda. Emerging ... -
The liver in HIV in Africa
(International Medical Press, 2005)As access to antiretroviral therapy improves across the African continent, liver disease is emerging as an important cause of morbidity and mortality among HIV-infected individuals. Although coinfection with hepatitis B ... -
Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: role of depression in declining adherence over time.
(Springer, 2009-03-20)We conducted a study to assess the effect of family-based treatment on adherence amongst HIV-infected parents and their HIV-infected children attending the Mother-To-Child-Transmission Plus program in Kampala, Uganda. ...